Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors
Molecules · 18.01.2024 · 29 (2) · 475
DOI: 10.3390/molecules29020475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 18.01.2024. Verfasst von Daowei Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China. Hauptthemen laut MEDLINE: Aniline Compounds, Antihypertensive Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Initial Research Project of High Level Talent in Hebei University of Chinese Medicine.
Abstract (Originalsprache)
Mer and c-Met kinases, which are commonly overexpressed in various tumors, are ideal targets for the development of antitumor drugs. This study focuses on the design, synthesis, and evaluation of several 2-substituted aniline pyrimidine derivatives as highly potent dual inhibitors of Mer and c-Met kinases for effective tumor treatment. Compound 18c emerged as a standout candidate, demonstrating robust inhibitory activity against Mer and c-Met kinases, with IC50 values of 18.5 ± 2.3 nM and 33.6 ± 4.3 nM, respectively. Additionally, compound 18c displayed good antiproliferative activities on HepG2, MDA-MB-231, and HCT116 cancer cells, along with favorable safety profiles in hERG testing. Notably, it exhibited exceptional liver microsomal stability in vitro, with a half-life of 53.1 min in human liver microsome. Compound 18c also exhibited dose-dependent cytotoxicity and hindered migration of HCT116 cancer cells, as demonstrated in apoptosis and migration assays. These findings collectively suggest that compound 18c holds promise as a dual Mer/c-Met agent for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
- State Key Laboratory Breeding Base-Hebei Key Laboratory of Molecular Chemistry for Drug, Shijiazhuang 050018, China.
- School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
- School of Food Science and Biology, Hebei University of Science and Technology, Shijiazhuang 050018, China.
- Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhe…
Förderung
- National Natural Science Foundation of China
- Initial Research Project of High Level Talent in Hebei University of Chinese Medicine
Zitieren
APA
Huang, D., Chen, Y., Yang, J., Zhao, B., Wang, S., Chai, T., Cui, J., Zhou, X., & Shang, Z. (2024). Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors. Molecules, 29(2), 475. https://doi.org/10.3390/molecules29020475
Vancouver
Huang D, Chen Y, Yang J, Zhao B, Wang S, Chai T, et al. Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors. Molecules. 2024;29(2):475. doi:10.3390/molecules29020475
BibTeX
@article{Huang2024,
author = {Huang, Daowei and Chen, Ying and Yang, Jixia and Zhao, Bingyang and Wang, Shouying and Chai, Tingting and Cui, Jie and Zhou, Xiaolei and Shang, Zhenhua},
title = {Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors},
journal = {Molecules},
year = {2024},
volume = {29},
number = {2},
pages = {475},
doi = {10.3390/molecules29020475}
}
EUVIMED